Novo Nordisk to Cut 9,000 Jobs in Global Restructuring
Novo Nordisk has announced a large global restructuring that will cut 9,000 jobs, a move the company says is necessary to streamline operations as the market for weight loss and diabetes drugs evolves.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →